GLOBUS MEDICAL, INC. Increase (Decrease) in Restricted Cash
GLOBUS MEDICAL, INC. (GMED) reported Increase (Decrease) in Restricted Cash of -$477.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-02-22
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was -$478.00K.
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $1.00K, a 99.87% decline year-over-year.
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $0.00.
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for fiscal 2017 was -$477.00K.
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for fiscal 2016 was -$25.64M, a 1032.74% decline from fiscal 2015.
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for fiscal 2015 was $2.75M, a 88.24% decline from fiscal 2014.
- GLOBUS MEDICAL, INC. increase (decrease) in restricted cash for fiscal 2014 was $23.37M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$478.00K derived: sum of 2 quarters · filed 2018-02-22 | -$477.00K derived: sum of 3 quarters · filed 2018-02-22 | -$477.00K 10-K · filed 2018-02-22 |
| 2017-09-30 | -$478.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$477.00K derived: sum of 2 quarters · filed 2017-11-09 | -$477.00K 10-Q · filed 2017-11-09 | -$476.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.00K 10-Q · filed 2017-08-03 | $2.00K derived: sum of 3 quarters · filed 2018-02-22 | -$10.76M derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $1.00K derived: sum of 2 quarters · filed 2018-02-22 | -$10.76M derived: sum of 3 quarters · filed 2018-02-22 | -$9.97M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$10.76M derived: sum of 2 quarters · filed 2018-02-22 | -$9.97M derived: sum of 3 quarters · filed 2018-02-22 | -$25.64M 10-K · filed 2018-02-22 |
| 2016-09-30 | -$10.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$9.97M derived: sum of 2 quarters · filed 2017-11-09 | -$25.64M 10-Q · filed 2017-11-09 | -$24.91M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $784.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$14.88M 10-Q · filed 2017-08-03 | -$14.15M derived: sum of 3 quarters · filed 2018-02-22 | -$13.45M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | -$15.67M 10-Q · filed 2017-05-04 | -$14.93M derived: sum of 2 quarters · filed 2018-02-22 | -$14.23M derived: sum of 3 quarters · filed 2018-02-22 | -$12.92M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $734.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.44M derived: sum of 2 quarters · filed 2018-02-22 | $2.75M derived: sum of 3 quarters · filed 2018-02-22 | $2.75M 10-K · filed 2018-02-22 |
| 2015-09-30 | $703.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.02M derived: sum of 2 quarters · filed 2016-11-09 | $2.02M 10-Q · filed 2016-11-09 | $25.39M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $1.31M 10-Q · filed 2016-07-27 | $24.68M derived: sum of 3 quarters · filed 2017-03-16 | $24.68M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-04 | $23.37M derived: sum of 2 quarters · filed 2017-03-16 | $23.37M derived: sum of 3 quarters · filed 2017-03-16 | |
| 2014-12-31 | $23.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $23.37M derived: sum of 2 quarters · filed 2017-03-16 | $23.37M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-31 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |